retatrutide blindness How works: mechanism of action and onset explained GLP 1 Blindness Risk |

savings cards)

O'Harte, Ulster University, United Kingdom Junhao Li, Viva Biotech, China Updates Copyright 2026 Singh, Shadangi and Rana

The South African Health Products Regulatory Authority (SAHPRA) has warned that potentially dangerous, falsified versions of semaglutide are being marketed in the country and urged the public to only use registered products sold at licensed pharmacies

Nestle has been producing these kinds of products for the elderly for decades (e.g

Increasing reports of severe side effects from users of GLP-1 agonist drugs, like Trulicity, have likely driven this rise in cases

[6] [10] Any preparation or use of retatrutide must only occur within an authorised clinical trial, under the supervision of qualified healthcare professionals